115 related articles for article (PubMed ID: 12528794)
21. Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells.
Minn H; Kangas L; Knuutila V; Paul R; Sipilä H
Res Exp Med (Berl); 1991; 191(1):27-35. PubMed ID: 2034887
[TBL] [Abstract][Full Text] [Related]
22. Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results.
Koechli OR; Avner BP; Sevin BU; Avner B; Perras JP; Robinson DS; Averette HE
J Surg Oncol; 1993 Oct; 54(2):119-25. PubMed ID: 8412158
[TBL] [Abstract][Full Text] [Related]
23. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
Nogaki M; Ichihashi H
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
[TBL] [Abstract][Full Text] [Related]
24. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
25. [Application of spectrophotometry to evaluation of the levels and the influence of chemotherapeutic drugs on ATP of malignant cell lines].
Wang H; Peng Z; Ding S
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):300-3. PubMed ID: 10684039
[TBL] [Abstract][Full Text] [Related]
26. Determination of chemotherapeutic activity in vivo by luminescent imaging of luciferase-transfected human tumors.
Caceres G; Zankina R; Zhu X; Jiao JA; Wong H; Aller A; Andreotti P
Anticancer Drugs; 2003 Aug; 14(7):569-74. PubMed ID: 12960742
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
28. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.
Kurbacher CM; Grecu OM; Stier U; Gilster TJ; Janát MM; Untch M; Konecny G; Bruckner HW; Cree IA
Recent Results Cancer Res; 2003; 161():221-30. PubMed ID: 12528810
[TBL] [Abstract][Full Text] [Related]
29. [Comparison between apoptosis cells count and ATP-bioluminescence assay in ovarian cancer chemosensitivity testing in vitro].
Lou J; Wang H; Liu S; Peng Z
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):267-9. PubMed ID: 12575205
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.
Louie KG; Hamilton TC; Shoemaker RH; Young RC; Ozols RF
Invest New Drugs; 1992 Jul; 10(2):73-8. PubMed ID: 1500268
[TBL] [Abstract][Full Text] [Related]
31. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
Qi CJ; Ning YL; Zhu YL; Min HY; Ye H; Qian KQ
Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
[TBL] [Abstract][Full Text] [Related]
32. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
[TBL] [Abstract][Full Text] [Related]
33. New luminescence-based approach to measurement of luciferase gene expression reporter activity and adenosine triphosphate-based determination of cell viability.
Konopka R; Hýzdalová M; Kubala L; Pacherník J
Folia Biol (Praha); 2010; 56(2):66-71. PubMed ID: 20492758
[TBL] [Abstract][Full Text] [Related]
34. [Cell culture and its application--in vitro evaluation of anticancer activity using human tumor cell lines].
Tashiro T
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2107-12. PubMed ID: 1329672
[TBL] [Abstract][Full Text] [Related]
35. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
36. Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assay.
Koechli OR; Sevin BU; Perras JP; Angioli R; Untch M; Steren A; Ramachandran C; Averette HE
Oncology; 1994; 51(6):552-8. PubMed ID: 7970502
[TBL] [Abstract][Full Text] [Related]
37. The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitro.
Moriyama EH; Niedre MJ; Jarvi MT; Mocanu JD; Moriyama Y; Subarsky P; Li B; Lilge LD; Wilson BC
Photochem Photobiol Sci; 2008 Jun; 7(6):675-80. PubMed ID: 18528551
[TBL] [Abstract][Full Text] [Related]
38. The MTS vs. the ATP assay for in vitro chemosensitivity testing of primary glioma tumour culture.
Dawson TP; Iyer RV; Lea RW; Roberts P; Harris E; Ashton K; Golash A; Davis CH
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):564-7. PubMed ID: 20524989
[No Abstract] [Full Text] [Related]
39. Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity.
Rose WC; Schurig JE; Meeker JB
Anticancer Res; 1988; 8(3):355-67. PubMed ID: 3389740
[TBL] [Abstract][Full Text] [Related]
40. In vitro assays of chemotherapeutic sensitivity.
Carney DN; Winkler CF
Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
